اعلان هااااااااااااااام


Translate

The World’s Only Transdermal Dopamin Agonist, Neupro® Patch, Approved in Japan for Both Parkinson’s Disease and Restless Legs Syndrome (Otsuka Pharmaceutical Co Ltd)

Tuesday, December 25, 2012

WN.com - Health News
Latest headlines from WN Network
The World's Only Transdermal Dopamin Agonist, Neupro® Patch, Approved in Japan for Both Parkinson's Disease and Restless Legs Syndrome (Otsuka Pharmaceutical Co Ltd)
Dec 25th 2012, 08:20

(Source: Otsuka Pharmaceutical Co Ltd) Otsuka Pharmaceutical Co., Ltd. December 25, 2012 The World's Only Transdermal Dopamin Agonist, Neupro® Patch, Approved in Japan for Both Parkinson's Disease and Restless Legs Syndrome The only transdermal dopamine agonist*1 system, which helps maintain a stable blood concentration of the drug treatment for 24 hours with once a day application Approved with indications for both Parkinson's Disease and Restless Legs*2 Syndrome Many patients are not satisfied with their treatment for Parkinson's Disease, and are long awaiting for drug which will be able to provide stable efficacy throughout the day to overcome their daily difficulties, such as not...
You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

0 Responses to The World’s Only Transdermal Dopamin Agonist, Neupro® Patch, Approved in Japan for Both Parkinson’s Disease and Restless Legs Syndrome (Otsuka Pharmaceutical Co Ltd)

Post a Comment